PTGER4
Basic information
Region (hg38): 5:40679915-40693735
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTGER4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 2 | 1 |
Variants in PTGER4
This is a list of pathogenic ClinVar variants found in the PTGER4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-40681033-C-G | not specified | Uncertain significance (Sep 14, 2023) | ||
5-40681249-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
5-40681256-G-A | not specified | Uncertain significance (Mar 29, 2024) | ||
5-40681285-A-T | not specified | Uncertain significance (Aug 21, 2024) | ||
5-40681459-A-C | not specified | Uncertain significance (Jan 11, 2023) | ||
5-40681524-C-A | not specified | Uncertain significance (Oct 12, 2021) | ||
5-40681552-A-G | not specified | Uncertain significance (Jan 29, 2024) | ||
5-40681591-G-A | not specified | Uncertain significance (Aug 03, 2022) | ||
5-40681610-T-C | not specified | Uncertain significance (Nov 08, 2024) | ||
5-40681616-G-C | not specified | Uncertain significance (Nov 24, 2024) | ||
5-40681705-T-A | not specified | Uncertain significance (Sep 23, 2023) | ||
5-40681715-A-C | not specified | Uncertain significance (Nov 05, 2021) | ||
5-40681755-T-G | not specified | Uncertain significance (Aug 26, 2022) | ||
5-40681777-C-G | not specified | Uncertain significance (Oct 25, 2024) | ||
5-40691791-G-A | not specified | Benign (Apr 17, 2015) | ||
5-40691923-A-C | not specified | Uncertain significance (Nov 17, 2022) | ||
5-40691982-G-T | not specified | Likely benign (Dec 21, 2023) | ||
5-40692015-G-C | not specified | Uncertain significance (Aug 27, 2024) | ||
5-40692118-G-A | not specified | Uncertain significance (Apr 16, 2024) | ||
5-40692248-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
5-40692292-G-A | not specified | Likely benign (Apr 07, 2022) | ||
5-40692307-G-C | not specified | Uncertain significance (Aug 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTGER4 | protein_coding | protein_coding | ENST00000302472 | 2 | 14238 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.976 | 0.0245 | 125744 | 0 | 3 | 125747 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.21 | 183 | 288 | 0.635 | 0.0000143 | 3117 |
Missense in Polyphen | 23 | 66.139 | 0.34775 | 760 | ||
Synonymous | 0.179 | 123 | 126 | 0.980 | 0.00000620 | 1072 |
Loss of Function | 3.45 | 1 | 15.8 | 0.0632 | 0.00000101 | 150 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000588 | 0.0000588 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000887 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function.;
- Pathway
- Inflammatory mediator regulation of TRP channels - Homo sapiens (human);Renin secretion - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;Small Ligand GPCRs;Vitamin D Receptor Pathway;GPCRs, Class A Rhodopsin-like;Prostaglandin Synthesis and Regulation;Signaling by GPCR;Signal Transduction;eicosanoid metabolism;G alpha (s) signalling events;Prostanoid ligand receptors;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Intolerance Scores
- loftool
- 0.0578
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.53
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- Y
- hipred_score
- 0.725
- ghis
- 0.476
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.714
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptger4
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype;
Zebrafish Information Network
- Gene name
- ptger4a
- Affected structure
- hematopoietic stem cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- inflammatory response;immune response;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;JNK cascade;response to mechanical stimulus;regulation of ossification;response to lipopolysaccharide;negative regulation of integrin activation;T-helper cell differentiation;negative regulation of cytokine secretion;positive regulation of cytokine secretion;negative regulation of inflammatory response;positive regulation of inflammatory response;regulation of stress fiber assembly;bone development;ERK1 and ERK2 cascade;cellular response to mechanical stimulus;cellular response to prostaglandin E stimulus;negative regulation of eosinophil extravasation
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- prostaglandin E receptor activity;protein binding